VAXX News and Press, Vaxxinity Inc. From 02/11/22

Investigator-sponsored studies show UB-612 induces high antibody activity against multiple variants, including Alpha, Beta, Delta, Gamma and Omicron, at levels similar to or higher than approved vaccines UB-612 elicits >3 times higher titers of neutralizing antibodies aga...

DALLAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first patient with Parkinson’s disease (PD) has been dosed with UB-312 in Part B of a double-blin...

DALLAS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ: VAXX), a clinical-stage biotech company pioneering a new class of immunotherapeutic vaccines to treat and prevent chronic neurological diseases, including Alzheimer’s and Parkinson’s, has announced that the com...

DALLAS, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced the appointment of Jason Pesile, MBA, CPA, as Senior Vice President, Finance & Accounting. The Company also a...

Vaxxinity (NASDAQ:VAXX): Q3 GAAP EPS of -$0.24. Revenue of $0.12M (+140.0% Y/Y) Press Release As of September 30, 2021, cash and cash equivalents were $89.4M. For further details see: Vaxxinity reports Q3 results

DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the third quarter ended September 30, 2021. “The completion of our recent initi...

Recently IPO’ed biotech Vaxxinity (VAXX +23.1%) has added more than a tenth to end six sessions of consecutive declines after Jefferies initiated the coverage on the stock with a Buy rating. The price target of $18 per share indicates a premium of ~145.9% to the last close. Nearly 2M V...

With another sharp decline, the shares of Vaxxinity (VAXX -18.4%) have extended the recent losses to the sixth straight session as the quiet period for the newly IPO’ed company expires. About 343.4K company shares have changed hands, compared to the 65-day average of ~662.7K. Dallas, T...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks closed out the week with a decline, but managed to limit some damage with last-hour buying. The Nasdaq (COMP.IND) -1.9% took the brunt...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...